
Coloplast posts 6% organic growth and 4% EBIT growth in FY 2025/26, sets strong 2030 financial targets.
Coloplast A/S reported a 6% organic revenue growth and 4% EBIT growth in constant currencies for fiscal year 2025/26, despite currency headwinds. The company achieved a 26% EBIT margin and increased adjusted net profit by DKK 418 million. Sustainabil...





